Hematoxylin and eosin staining was performed to confirm xenograft tumor morphology, and immunohistochemical staining was performed to show the decreased positive rates of proliferation markers ki-67 and proliferating cell nuclear antigen (PCNA) (Figure 3C). Here, PCNA is linked to neoplasm.